Orphanbiotec | Business
9619
page-template-default,page,page-id-9619,page-parent,ajax_fade,page_not_loaded,,side_area_uncovered_from_content,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Business

Core Business Overview

Business model

Based on Orphanbiotec’s special collaboration with expert partners such as the Orphanbiotec Research Foundation and other R&D partners, ...

Strategy

Since many orphan diseases are life-threatening and no alternative treatment is available, it has been possible to achieve a very ...

Partnership

As a research-driven pharmaceutical company, Orphanbiotec will still need several years before it can begin to market the drugs developed. ...

Impact

Some pharmaceutical company are able or willing to help People with Rare Diseases. For those affected, we develop innovative Orphan ...

Sustainability

We are using established knowledge before new substances. Why? Because there is knowledge available that dates back over 2000 years ...

Empowerment

The Orphanbiotec Foundation takes care of patients affected by a rare disease and their families. The Patient-Empowerment-Program Elfen Helfen® (Little ...